BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Akateh C, Black SM, Conteh L, Miller ED, Noonan A, Elliott E, Pawlik TM, Tsung A, Cloyd JM. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World J Gastroenterol 2019; 25(28): 3704-3721 [PMID: 31391767 DOI: 10.3748/wjg.v25.i28.3704]
URL: https://www.wjgnet.com/1007-9327/full/v25/i28/3704.htm
Number Citing Articles
1
Maowen Yu, Chaozhu Zhang, Hongbo Tang, Chaohui Xiao, Hangjun Che. Correlation between Serum Oxidative Stress Level and Serum Uric Acid and Prognosis in Patients with Hepatitis B-Related Liver Cancer before OperationJournal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/1964866
2
Christopher D. Griffiths, Betty Zhang, Kasia Tywonek, Brandon M. Meyers, Pablo E. Serrano. Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular CarcinomaJAMA Network Open 2022; 5(7): e2222721 doi: 10.1001/jamanetworkopen.2022.22721
3
Qi Pan, Zigong Shao, Yijie Zhang, Hao Liu. MicroRNA-1178-3p suppresses the growth of hepatocellular carcinoma by regulating transducin (beta)-like 1 X-linked receptor 1Human Cell 2021; 34(5): 1466 doi: 10.1007/s13577-021-00565-5
4
Stefanie J. Hectors, Sara Lewis, Cecilia Besa, Michael J. King, Daniela Said, Juan Putra, Stephen Ward, Takaaki Higashi, Swan Thung, Shen Yao, Ilaria Laface, Myron Schwartz, Sacha Gnjatic, Miriam Merad, Yujin Hoshida, Bachir Taouli. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinomaEuropean Radiology 2020; 30(7): 3759 doi: 10.1007/s00330-020-06675-2
5
Hao Wu, Jinrui Zhang, Yi Bai, Sai Zhang, Zhixin Zhang, Wen Tong, Pinsheng Han, Bing Fu, Yamin Zhang, Zhongyang Shen. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinomaAging 2021; 13(19): 23020 doi: 10.18632/aging.203593
6
Kevin P. Labadie, Jonathan G. Sham. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for EverybodyAnnals of Surgical Oncology 2020; 27(11): 4070 doi: 10.1245/s10434-020-08702-4
7
Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis, Alexandros Hardas, Athanasios Pseftogas, Kali Makedou, Athanasios Gargavanis, Thomas Goulopoulos, Stavros Iliadis, Vasileios Papadopoulos, Apostolos Papalois, George Mosialos, Theofilos Poutahidis, Dimitrios Giakoustidis. <p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>OncoTargets and Therapy 2020; : 5575 doi: 10.2147/OTT.S250233
8
Clifford Akateh, Aslam M Ejaz, Timothy Michael Pawlik, Jordan M Cloyd. Neoadjuvant treatment strategies for intrahepatic cholangiocarcinomaWorld Journal of Hepatology 2020; 12(10): 693-708 doi: 10.4254/wjh.v12.i10.693
9
Yao-chang Luo, Hai-lin Lu, Wen-ling Song, Fei-fei Xuan. Multidisciplinary treatment of advanced hepatocellular carcinoma with severe arterioportal shunt: a case reportJournal of International Medical Research 2021; 49(7): 030006052110248 doi: 10.1177/03000605211024840
10
Ying Liu, Yuzhu Wang, Xinkun Guo, Yifeng He, Jian Zhou, Qianzhou Lv, Xiaowu Huang, Xiaoyu Li. Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-AnalysisFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.709278
11
Hu Chen, Minglei Teng, Hongrui Zhang, Xiaoliu Liang, Hongwei Cheng, Gang Liu. Advanced radionuclides in diagnosis and therapy for hepatocellular carcinomaChinese Chemical Letters 2022; 33(7): 3371 doi: 10.1016/j.cclet.2022.03.079
12
Daniel W. Nelson, Jean-Nicolas Vauthey. Optimizing Treatment Strategies with Preoperative Assessment for Microvascular Invasion in Hepatocellular CarcinomaAnnals of Surgical Oncology 2022;  doi: 10.1245/s10434-022-12746-z
13
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi. Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothingFuture Oncology 2020; 16(32): 2587 doi: 10.2217/fon-2020-0669
14
Bi Peng, Yuanliang Yan, Zhijie Xu. The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinomaPeerJ 2021; 9: e12123 doi: 10.7717/peerj.12123
15
Ahmed N. Elfadaly, Diamantis I. Tsilimigras, J. Madison Hyer, Alessandro Paro, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional AnalysisWorld Journal of Surgery 2021; 45(11): 3438 doi: 10.1007/s00268-021-06265-3
16
Mark A. Healy, Michael A. Choti. Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging TherapiesAnnals of Surgical Oncology 2022; 29(7): 4030 doi: 10.1245/s10434-022-11709-8
17
Qi Huo, Junjie Hu, Binfen Hou, Mei Zhao, Xue Han, Yulin Du, Yao Li. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer PatientsPathology and Oncology Research 2022; 28 doi: 10.3389/pore.2022.1610396
18
Taicheng Lu, Liying Wei, Xiaoqing Huang, Yin Li, Guo Li, Qixiao Qin, Meishi Pan, Bingling Tang, Xin Pan, Mei Wei, Zhenzhen Nong, Fayan Meng, Xuehua Li. A potentially valuable nano graphene oxide/USPIO tumor diagnosis and treatment systemMaterials Science and Engineering: C 2021; 128: 112293 doi: 10.1016/j.msec.2021.112293
19
Francesco Izzo, Meredith C. Mason, Eric J. Silberfein, Nader N. Massarweh, Cary Hsu, Hop S. Tran Cao, Raffaele Palaia, Mauro Piccirillo, Andrea Belli, Renato Patrone, Roberta Fusco, Vincenza Granata, Steven A. Curley. Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during ScreeningBiology 2022; 11(11): 1597 doi: 10.3390/biology11111597
20
Tomohiro Ishinuki, Shigenori Ota, Kohei Harada, Hiroomi Tatsumi, Keisuke Harada, Koji Miyanishi, Minoru Nagayama, Ichiro Takemasa, Toshio Ohyanagi, Thomas T Hui, Toru Mizuguchi. Health-related quality of life in patients that have undergone liver resection: A systematic review and meta-analysisWorld Journal of Meta-Analysis 2021; 9(1): 88-100 doi: 10.13105/wjma.v9.i1.88
21
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management StrategiesCancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
22
Shun-Chao Yang, Lei Liang, Ming-Da Wang, Xian-Ming Wang, Li-Hui Gu, Kong-Ying Lin, Ya-Hao Zhou, Ting-Hao Chen, Wei-Min Gu, Jie Li, Hong Wang, Zhong Chen, Chao Li, Lan-Qing Yao, Yong-Kang Diao, Li-Yang Sun, Cheng-Wu Zhang, Yong-Yi Zeng, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang. Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from ChinaHPB 2022;  doi: 10.1016/j.hpb.2022.09.002
23
Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinomaWorld Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550
24
Francesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, Rita Balsano, Federico Piacentini, Massimo Dominici, Fabio Gelsomino. The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A ReviewPharmaceuticals 2021; 14(1): 43 doi: 10.3390/ph14010043
25
Elise Vène, Kathleen Jarnouen, Catherine Ribault, Manuel Vlach, Yann Verres, Mickaël Bourgeois, Nicolas Lepareur, Sandrine Cammas-Marion, Pascal Loyer. Circumsporozoite Protein of Plasmodium berghei- and George Baker Virus A-Derived Peptides Trigger Efficient Cell Internalization of Bioconjugates and Functionalized Poly(ethylene glycol)-b-poly(benzyl malate)-Based Nanoparticles in Human Hepatoma CellsPharmaceutics 2022; 14(4): 804 doi: 10.3390/pharmaceutics14040804
26
Jin Hong Lim, Keunwan Park, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan, Seok-Mo Kim, Ki Cheong Park. Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2022; 23(14): 7971 doi: 10.3390/ijms23147971
27
Changying Shi, Yong Li, Li Geng, Weifeng Shen, Chengjun Sui, Binghua Dai, Jiongjiong Lu, Mianshun Pan, Jiamei Yang. Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trialEuropean Journal of Cancer 2022; 166: 176 doi: 10.1016/j.ejca.2022.02.012
28
Chien Peter Chen. Role of External Beam Radiotherapy in Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 701 doi: 10.1016/j.cld.2020.07.006
29
Alessandro Fancellu, Valeria Sanna, Fabrizio Scognamillo, Claudio F Feo, Gianpaolo Vidili, Giuseppe Nigri, Alberto Porcu. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendationsWorld Journal of Clinical Cases 2021; 9(15): 3517-3530 doi: 10.12998/wjcc.v9.i15.3517
30
Clarisse Brossard, Manuel Vlach, Elise Vène, Catherine Ribault, Vincent Dorcet, Nicolas Noiret, Pascal Loyer, Nicolas Lepareur, Sandrine Cammas-Marion. Synthesis of Poly(Malic Acid) Derivatives End-Functionalized with Peptides and Preparation of Biocompatible Nanoparticles to Target Hepatoma CellsNanomaterials 2021; 11(4): 958 doi: 10.3390/nano11040958
31
John R. Bergquist, Amy Y. Li, Christopher S. Javadi, Byrne Lee, Jeffrey A. Norton, George A. Poultsides, Monica M. Dua, Brendan C. Visser. Regional lymph node sampling in hepatoma resection: insight into prognosisHPB 2021; 23(9): 1360 doi: 10.1016/j.hpb.2021.01.006
32
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an updateClinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
33
Kexin Wang, Xiangmin Ye, Chuanhui Yin, Qing Ren, Yupeng Chen, Xuemei Qin, Chuanzhi Duan, Aiping Lu, Li Gao, Daogang Guan. Computational Metabolomics Reveals the Potential Mechanism of Matrine Mediated Metabolic Network Against Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.859236
34
Nicole M. Nevarez, Gloria Y. Chang, Adam C. Yopp. An Overview of Clinical Trials in the Treatment of Resectable Hepatocellular CarcinomaSurgical Oncology Clinics of North America 2023; 32(1): 101 doi: 10.1016/j.soc.2022.07.008
35
Zhifeng Lin, Xuqiong Huang, Xiaohui Ji, Nana Tian, Yu Gan, Li Ke. Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinomaScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13159-4
36
Lan-Qing Yao, Zheng-Liang Chen, Zi-Han Feng, Yong-Kang Diao, Chao Li, Hai-Ying Sun, Jian-Hong Zhong, Ting-Hao Chen, Wei-Min Gu, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Yong-Yi Zeng, Han Wu, Ming-Da Wang, Xin-Fei Xu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Tian Yang. Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional AnalysisAnnals of Surgical Oncology 2022; 29(7): 4291 doi: 10.1245/s10434-022-11454-y
37
Lisa S. Parks, Patricia Little. Cirrhosis, Hepatocellular Carcinoma, and Locoregional TherapiesJournal of Radiology Nursing 2022; 41(2): 129 doi: 10.1016/j.jradnu.2022.01.005
38
Ahmed Montasser, Aurélie Beaufrère, François Cauchy, Mohamed Bouattour, Olivier Soubrane, Miguel Albuquerque, Valérie Paradis. Transarterial chemoembolisation enhances programmed death‐1 and programmed death‐ligand 1 expression in hepatocellular carcinomaHistopathology 2021; 79(1): 36 doi: 10.1111/his.14317
39
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong Lim. Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case reportJournal of Liver Cancer 2022; 22(1): 84 doi: 10.17998/jlc.2022.03.07
40
Hai-Tao Zhao, Jian-Qiang Cai. Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinomaWorld Journal of Gastroenterology 2021; 27(47): 8069-8080 doi: 10.3748/wjg.v27.i47.8069
41
Zhenchang Wang, Yunjie Duan, Jinmei Zhang, Yanhang Lv, Shanshan Wu, Mingrong Cheng, Akshaya Srikanth Bhagavathula, Wafa Ali Aldhaleei, Cain Clark, Zongwei Huo. Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: A meta-analysisEuropean Journal of Pharmacology 2020; 883: 173382 doi: 10.1016/j.ejphar.2020.173382
42
Hiroji Shinkawa, Shogo Tanaka, Shigekazu Takemura, Ryosuke Amano, Kenjiro Kimura, Masahiko Kinoshita, Kanae Takahashi, Shuichiro Matsuzaki, Shoji Kubo. Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinomaSurgery 2021; 169(4): 922 doi: 10.1016/j.surg.2020.10.012
43
Min Wang, Shan Huang, Zefeng Chen, Zhiwei Han, Kezhi Li, Chuang Chen, Guobin Wu, Yinnong Zhao. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07625-3
44
Chiun Hsu, Lorenza Rimassa, Hui-Chuan Sun, Arndt Vogel, Ahmed O. Kaseb. Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumabTherapeutic Advances in Medical Oncology 2021; 13: 175883592110311 doi: 10.1177/17588359211031141
45
Bin Yu, Han Liang, Qifa Ye, Yanfeng Wang. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 ResectionJournal of Gastrointestinal Surgery 2021; 25(1): 112 doi: 10.1007/s11605-020-04554-1
46
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experienceAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 67 doi: 10.16931/1995-5464.2020267-76
47
Zeyu Wang, Ningning Zhang, Jiayu Lv, Cuihua Ma, Jie Gu, Yawei Du, Yibo Qiu, Zhiguang Zhang, Man Li, Yong Jiang, Jianqiu Zhao, Huiqin Du, Zhiwei Zhang, Wei Lu, Yan Zhang, Luca Miele. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma PatientsBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4037639
48
Andreas Koulouris, Christos Tsagkaris, Vasiliki Spyrou, Eleni Pappa, Aikaterini Troullinou, Michail Nikolaou. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment OptionsJournal of Hepatocellular Carcinoma 2021; : 387 doi: 10.2147/JHC.S300182
49
Ming-Da Wang, Hao Xiang, Ling Zhang, Chao Wang. Integration of OV6 expression and CD68+ tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinomaTranslational Oncology 2022; 25: 101509 doi: 10.1016/j.tranon.2022.101509
50
Suchira Gallage, María García-Beccaria, Marta Szydlowska, Mohammad Rahbari, Raphael Mohr, Frank Tacke, Mathias Heikenwalder. The therapeutic landscape of hepatocellular carcinomaMed 2021; 2(5): 505 doi: 10.1016/j.medj.2021.03.002
51
Tao Wei, Xu-Feng Zhang, Feng Xue, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Silvia Silva, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Razvan Grigorie, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular CarcinomaAnnals of Surgical Oncology 2021; 28(12): 7624 doi: 10.1245/s10434-021-10142-7
52
Jie Jian, Yuan Nie, Chenkai Huang, Sizhe Wan, Xuan Zhu. A scoring model predicting overall survival for hepatocellular carcinoma patients who receive surgery and chemotherapyIndian Journal of Surgery 2022; 84(S2): 365 doi: 10.1007/s12262-021-03224-z
53
H. Lang, S. Heinrich, F. Bartsch, F. Hüttl, J. Baumgart, J. Mittler. Chirurgische Therapie bei Lebertumoren – Leberresektion und -transplantationDer Internist 2020; 61(2): 147 doi: 10.1007/s00108-020-00754-8
54
Seok-Mo Kim, Keunwan Park, Jin Hong Lim, Hyeok Jun Yun, Sang Yong Kim, Kyung Hwa Choi, Chan Wung Kim, Jae Ha Lee, Raymond Weicker, Cheol-Ho Pan, Ki Cheong Park. Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid CarcinomaInternational Journal of Molecular Sciences 2022; 23(18): 10378 doi: 10.3390/ijms231810378
55
Stepan M. Esagian, Christos D. Kakos, Emmanouil Giorgakis, Lyle Burdine, J. Camilo Barreto, Michail N. Mavros. Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsCancers 2021; 13(12): 2984 doi: 10.3390/cancers13122984
56
Seo Yeon Youn, Bohyun Kim, Dong Hwan Kim, Ho Joong Choi, Pil Soo Sung, Joon-Il Choi. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy–treated hepatocellular carcinomaEuropean Radiology 2022; 32(9): 6270 doi: 10.1007/s00330-022-08720-8
57
Qimeng Wang, Jin Huang, Huihua Zhang, Huan Liu, Min Yu. Identification and analysis of immune-related subtypes of hepatocellular carcinomaExperimental Biology and Medicine 2021; 246(6): 667 doi: 10.1177/1535370220970130
58
Claudia A. M. Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato. Immunotherapy in Hepatocellular CarcinomaCurrent Treatment Options in Oncology 2021; 22(10) doi: 10.1007/s11864-021-00886-5
59
Congjian Shi, Hongqin Yang, Zhenghong Zhang. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver DiseasesFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00139
60
Gi Hong Choi. Radiotherapy of Liver Cancer2021; : 209 doi: 10.1007/978-981-16-1815-4_15
61
Fuli Xin, Ming Wu, Zhixiong Cai, Xiaolong Zhang, Zuwu Wei, Xiaolong Liu, Jingfeng Liu. Tumor Microenvironment Triggered Cascade‐Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular CarcinomaAdvanced Healthcare Materials 2021; 10(10): 2002036 doi: 10.1002/adhm.202002036
62
Amblessed E. Onuma, Hongji Zhang, Hai Huang, Terence M. Williams, Anne Noonan, Allan Tsung. Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to TreatmentGene Expression 2020; 20(1): 53 doi: 10.3727/105221620X15880179864121
63
Atsushi Oyama, Kazuhiro Nouso, Kenichi Yoshimura, Yuki Morimoto, Shinichiro Nakamura, Hideki Onishi, Akinobu Takaki, Shouta Iwadou, Kazuya Kariyama, Kenji Kuwaki, Kazuhisa Yabushita, Kosaku Sakaguchi, Jyunichi Toshimori, Haruhiko Kobashi, Akio Moriya, Masaharu Ando, Hiroyuki Okada. Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinomaHepatology Research 2021; 51(6): 694 doi: 10.1111/hepr.13633
64
Xiao-Xue Gou, Hong-Yun Shi, Chao Li, Zheng-Liang Chen, Wei Ouyang, Li-Yang Sun, Yong-Kang Diao, Ming-Da Wang, Lan-Qing Yao, Li-Hui Gu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Jun Xue, Tian Yang. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched StudyInternational Journal of Radiation Oncology*Biology*Physics 2022; 114(2): 238 doi: 10.1016/j.ijrobp.2022.05.020
65
Giovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, Stefano Di Donato, Marianna Silletta, Paolo Gallo, Angelo Onorato, Umberto Vespasiani-Gentilucci, Antonio Picardi. Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver CirrhosisCurrent Drug Metabolism 2020; 21(11): 866 doi: 10.2174/1389200221999200918141239